Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Relative Risk
Actuarial Approach
Unrealistic Optimism Bias
Introspection
Magical Thinking
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Apr 4, 2026

Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods
Published on: September 19, 2012
1Ross Cagan is Editor-in-Chief of Disease Models & Mechanisms and is Senior Associate Dean of the Graduate School of Biomedical Sciences at the Icahn School of Medicine at Mount Sinai, New YorkIcahn School of Medicine at Mount Sinai, Annenberg 25-40, Campus Box 1020, 1468 Madison Avenue, New York, NY 10029, USA ross.cagan@mssm.edu.
Scientific training should encourage embracing risk, not just safe exploration. We must prepare the next generation of scientists to tackle difficult problems by fostering a culture that values calculated risk-taking.
Area of Science:
Background:
Discussion:
Key Insights:
Outlook: